Navigation Links
Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
Date:4/23/2009

Anadys Pharmaceuticals, Inc. Condensed Consolidated Statements of Operations (In thousands except per share amounts) (Unaudited) Three Months Ended March 31, 2009 2008 Operating expenses Research and development $ 6,876 $ 6,009 General and administrative 2,055 2,045 Total operating expenses(1) 8,931 8,054 Interest income and other, net 172 610 Net loss(1) $ (8,759) $ (7,444) Net loss per share, basic and diluted(1) $ (0.30) $ (0.26) Share used in calculating net loss per share, basic and diluted 28,838 28,697

(1) Includes non-cash operating expenses of $684 and $661 determined in accordance with Statement of Financial Accounts Standards No. 123(R), "Share-Based Payment" (SFAS No. 123(R)) or approximately $0.02 and $0.02 effect on basic and diluted net loss per common share for the three months ended March 31, 2009 and 2008, respectively. Research and development expense and general and administrative expense includes $328 and $356 of non-cash operating expenses determined in accordance with SFAS No. 123(R) for the three months ended March 31, 2009. Research and development expense and general and administrative expense includes $310 and $351 of non-cash operating expenses determined in accordance with SFAS No. 123(R) for the three months ended March 31, 2008.

                         Anadys Pharmaceuticals, Inc.
                     Condensed Consolidated Balance Sheets
                              (In th
'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
2. Anadys Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
7. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
9. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
10. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
11. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... ALEXANDRIA, Va. , April 30, 2015 ... provides senior debt to life sciences and healthcare services ... senior secured term loan agreement with Celula, Inc., a ... diagnosing major diseases, enabling better patient care and improved ... continue the development and expand the commercialization of its ...
(Date:4/30/2015)... , April 30, 2015  Pfenex Inc. (NYSE ... the development of biosimilar therapeutics including high value ... closing of its previously announced underwritten public offering ... a public offering price of $15.50 per share. ... underwriters of their option to purchase up to ...
(Date:4/30/2015)... Available in select spas in the ... Fleur’s introduces CC CRÈME Perfect Skin ... makeup, skin care and solar protection in one ... with specific complexion-correcting pigments to instantly blur flaws ... healthy glow. Far more than a concealer, it ...
(Date:4/30/2015)... Sterlitech is proud to offer Synder ... PY, and PZ Polyacrylonotrile (PAN) membranes , as ... to be ideal for oil removal in wastewater ... process requirements where the presence of oils in ... on industrial wastewater discharge and quality requirements for ...
Breaking Biology Technology:Oxford Finance Provides $10 Million Debt Financing to Celula 2Pfenex Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2Fleur’s Introduces CC CRÈME Perfect Skin Solution 2Fleur’s Introduces CC CRÈME Perfect Skin Solution 3Sterlitech Offers New Ultrafiltration Membranes 2
... Stem Cell Therapy Better Option for Humans, ... in English,for the first time, The British Institute ... Therapy) training to U.S. medical and,homeopathic practitioners for ... Plant stem cell therapy is more advantageous because,it ...
... Jan. 28 /PRNewswire-FirstCall/ - Quest PharmaTech Inc.,("Quest" ... has signed a,collaborative research agreement with the ... combination therapy for the treatment of lung ... lead oncology product,SL052, with various immunotherapeutic agents. ...
... Phytomedics Inc., a clinical,stage biopharmaceutical company developing novel ... will present at the,Wachovia 2008 Healthcare Conference in ... ET., Among the topics of the presentation ... business developments, including Phase III development,activities related to ...
Cached Biology Technology:Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 3
(Date:4/27/2015)... April 27, 2015  For more than four decades, ... has been the premier worldwide event for the unmanned ... a must-attend event for any local, national, or trade ... emerging commercial markets and current applications of unmanned technologies. ... this projected $48 billion industry, and how it will ...
(Date:4/27/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® Smart ... week of May, 2015 and will be fulfilling all ... Gino Pereira , Chief Executive Officer said, ... Wocket® enters the consumer market. We would like to ...
(Date:4/27/2015)... , Apr. 27, 2015 Profile Solutions, Inc. ... and security systems is pleased to announce that Dr ... a consultant and member of its scientific advisory board. ... known as a thought leader in technology-enhanced learning models. ... Group, and has published studies and books focused on ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... Friday, April 20, 2012 Researchers from Cleveland ... greater consumption of sugar-sweetened and low-calorie sodas is associated ... caffeinated or decaffeinated coffee was associated with a lower ... American Journal of Clinical Nutrition is ...
... On the second anniversary of the Deepwater Horizon blowout, ... scientist Samantha Joye is urging the federal government to reassess ... occur in the future. The 22 researchers, whose paper ... , noted that the 2010 Deepwater Horizon oil spill was ...
... 19, 2012 From cognitive neuroscience to theoretical ... Research Fellows from the University of Houston (UH) ... ranging from medicine to energy. Recognizing ... in NSF-supported science, technology, engineering and mathematics disciplines, ...
Cached Biology News:Study finds soda consumption increases overall stroke risk 2Marine scientists urge government to reassess oil spill response 2Marine scientists urge government to reassess oil spill response 3Marine scientists urge government to reassess oil spill response 45 NSF Graduate Research Fellowships awarded to UH students, alumna 25 NSF Graduate Research Fellowships awarded to UH students, alumna 3
... bioassays for interferons are cytopathic effect inhibition ... assays. The neutralization assay measures the ... of the cytokine. Sample types include; tissue ... In these assays, one unit is defined ...
... and Protein G bind specifically to Fc ... and Protein G conjugates are commonly used ... and immunoglobulin subtypes from serum, hybridoma ascites ... fluids. These reagents are also commonly used ...
... complete, flexible system designed specifically for ... is frequently required in biological research. ... miniature Clark-style polarographic electrode. Measuring only ... (3.2 mm), it is ideal for ...
... is a member of the family of human cullin ... to the S. cerevisiae cdc53 gene. Cullin-3 is proposed ... forms a tight complex with cyclin E and targets ... protesomes. Cyclin E is an activator of cdk2, which ...
Biology Products: